Patents/Inventors

Shrikant Deshpande

Fremont, CAUS5 patents

5 Patents

US124417992025
Activatable Anti-ctla-4 Antibodies and Uses Thereof
Cytomx Therapeutics, Inc.
0 cites
US121103372024
Anti-cd27 Antibodies and Uses Thereof
Bristol-myers Squibb Company
0 cites
US120775842024
Methods of Treating Hla-e-expressing Cancers by Administering Antibodies Which Bind Human Natural Killer Cell Inhibitory Receptor Group 2A (NKG2A)
Bristol-myers Squibb Company
0 cites
US119817342024
Nucleic Acid Molecules Encoding Antibodies Which Bind Natural Killer Cell Inhibitory Receptor Group 2A Protein (NKG2A)
Bristol-myers Squibb Company
0 cites
US117084052023
IP-10 Antibodies and Their Uses
BRISTOL-MYERS QUIBB COMPANY
0 cites